Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

NCT: NCT06891755 · RECRUITING

NCT IDNCT06891755
StatusRECRUITING
Start Date2025-07-15
Completion2029-12-31

Brief Summary

The objective of this study is to assess the safety and efficacy of Apreo BREATHE system when used to support native airways and release trapped air in the treatment of adult COPD patients with emphysema suffering from dyspnea due to hyperinflation despite optimal medical treatment. The Apreo BREATHE Airway Scaffold is a permanent implant designed to tent open native airways. The study will include up to 250 participants at up to 25 study centers located in the United States and Europe. Study subjects will be followed for 3 years. The main questions it aims to answer are: Is it safe? Does it work?

Frequently Asked Questions

What is Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3?

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3 is a clinical trial registered under NCT06891755. Current status: RECRUITING.

What is the status of NCT06891755?

The current status of NCT06891755 (Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3) is: RECRUITING.

When did Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3 start?

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3 started on 2025-07-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑